Blackstone Group »

Arrowhead Pharmaceuticals shares owned by Blackstone Group

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Blackstone Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $802k 13k 62.70

More positions owned by Blackstone Group

Cheniere Energy Partners Com Unit (CQP)
Corebridge Finl (CRBG)
FirstEnergy (FE)
Legence Corp Cl A (LGN)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Williams Companies (WMB)
MPLX Com Unit Rep Ltd (MPLX)
Targa Res Corp (TRGP)
Enterprise Products Partners (EPD)
Enbridge (ENB)
Kinder Morgan (KMI)
Energy Transfer Com Ut Ltd Ptn (ET)
Kinetik Holdings Com New Cl A (KNTK)
Cheniere Energy Com New (LNG)
PNM Resources (TXNM)

View all positions for Blackstone Group

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
Vanguard Portfolio Management
FMR
State Street Corporation
Vanguard Capital Management
Geode Capital Management
Fred Alger Management
Invesco
Slate Path Capital
Vestal Point Capital
Arrowstreet Capital, Limited Partnership
Baker Bros. Advisors
Driehaus Capital Management

View all funds holding Arrowhead Pharmaceuticals